These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27022389)

  • 1. Differential Roles of Peroxisome Proliferator-Activated Receptor-α and Receptor-γ on Renal Crystal Formation in Hyperoxaluric Rodents.
    Taguchi K; Okada A; Hamamoto S; Unno R; Kobayashi T; Ando R; Tozawa K; Gao B; Kohri K; Yasui T
    PPAR Res; 2016; 2016():9605890. PubMed ID: 27022389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone, a peroxisome proliferator activated receptor γ agonist, decreases renal crystal deposition, oxidative stress and inflammation in hyperoxaluric rats.
    Taguchi K; Okada A; Yasui T; Kobayashi T; Ando R; Tozawa K; Kohri K
    J Urol; 2012 Sep; 188(3):1002-11. PubMed ID: 22819112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
    Nakano Y; Arima T; Tobita Y; Uchiyama M; Shimizu A; Takahashi H
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs.
    Helmy MM; Helmy MW; El-Mas MM
    PLoS One; 2015; 10(11):e0142303. PubMed ID: 26536032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
    Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
    Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress.
    Sekulic-Jablanovic M; Petkovic V; Wright MB; Kucharava K; Huerzeler N; Levano S; Brand Y; Leitmeyer K; Glutz A; Bausch A; Bodmer D
    PLoS One; 2017; 12(11):e0188596. PubMed ID: 29182629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
    Koufany M; Jouzeau JY; Moulin D
    Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
    Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
    Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats.
    Stunes AK; Westbroek I; Gustafsson BI; Fossmark R; Waarsing JH; Eriksen EF; Petzold C; Reseland JE; Syversen U
    BMC Endocr Disord; 2011 May; 11():11. PubMed ID: 21615901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone.
    Syversen U; Stunes AK; Gustafsson BI; Obrant KJ; Nordsletten L; Berge R; Thommesen L; Reseland JE
    BMC Endocr Disord; 2009 Mar; 9():10. PubMed ID: 19331671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells.
    Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H
    J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor γ modulates renal crystal retention associated with high oxalate concentration by regulating tubular epithelial cellular transdifferentiation.
    Li S; Lan Y; Wu W; Duan X; Kong Z; Wu W; Zeng G
    J Cell Physiol; 2019 Mar; 234(3):2837-2850. PubMed ID: 30317563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver.
    Won TW
    Korean J Hepatobiliary Pancreat Surg; 2013 Aug; 17(3):89-108. PubMed ID: 26155222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
    Omeragic A; Hoque MT; Choi UY; Bendayan R
    J Neuroinflammation; 2017 Sep; 14(1):183. PubMed ID: 28886715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
    Zuo N; Zheng X; Liu H; Ma X
    Int J Clin Exp Pathol; 2015; 8(9):10653-61. PubMed ID: 26617775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.
    Gelosa P; Banfi C; Gianella A; Brioschi M; Pignieri A; Nobili E; Castiglioni L; Cimino M; Tremoli E; Sironi L
    J Pharmacol Exp Ther; 2010 Nov; 335(2):324-31. PubMed ID: 20671072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.